Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
“Global vascular grafts market projected to grow at a CAGR of 7.3% during the forecast period”
The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other risk factors that promote aneurysms.
“The polyester segment is expected to grow at the highest growth rate during the forecast period”
On the basis of raw material, the vascular grafts market is segmented into ePTFE grafts, polyester grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts are expected to grow at the highest CAGR during the forecast period. The high growth rate of the segment can be attributed to the fact that most newly launched vascular grafts are made of polyester and because the advantages it offers such as high patency, high porousness, and reduced post-surgery side effects.
“The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the forecast period”
On the basis of indication, the vascular grafts market is classified into endovascular aneurysm repair or EVAR, hemodialysis access, and peripheral vascular aneurysm. The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the analysis period. The growth of this segment is mainly driven by the rising adoption of endovascular aneurysm repair surgical procedures, increasing preference for minimally invasive surgical procedures over open surgeries, and growing geriatric population.
“Asia Pacific is estimated to grow at the highest CAGR during the study period”
Geographically, the vascular grafts market is dominated by North America, followed by Europe in 2017, however, Asia Pacific is estimated to grow at the fastest rate during the forecast period. Growth in the APAC region can be attributed to the rising prevalence of chronic kidney disease, healthcare reforms, government initiatives and investments, and rapid growth in geriatric population. Emerging markets in the region, such as Australia, Singapore, Japan, and China also offer numerous growth opportunities for players operating in the vascular grafts.
The primary interviews conducted for this report can be categorized as follows:
Research Coverage:
The report analyses the vascular grafts market by indication, raw material, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. This report also includes market research data, current market size, and forecast of the future trends that will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other risk factors that promote aneurysms.
“The polyester segment is expected to grow at the highest growth rate during the forecast period”
On the basis of raw material, the vascular grafts market is segmented into ePTFE grafts, polyester grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts are expected to grow at the highest CAGR during the forecast period. The high growth rate of the segment can be attributed to the fact that most newly launched vascular grafts are made of polyester and because the advantages it offers such as high patency, high porousness, and reduced post-surgery side effects.
“The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the forecast period”
On the basis of indication, the vascular grafts market is classified into endovascular aneurysm repair or EVAR, hemodialysis access, and peripheral vascular aneurysm. The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the analysis period. The growth of this segment is mainly driven by the rising adoption of endovascular aneurysm repair surgical procedures, increasing preference for minimally invasive surgical procedures over open surgeries, and growing geriatric population.
“Asia Pacific is estimated to grow at the highest CAGR during the study period”
Geographically, the vascular grafts market is dominated by North America, followed by Europe in 2017, however, Asia Pacific is estimated to grow at the fastest rate during the forecast period. Growth in the APAC region can be attributed to the rising prevalence of chronic kidney disease, healthcare reforms, government initiatives and investments, and rapid growth in geriatric population. Emerging markets in the region, such as Australia, Singapore, Japan, and China also offer numerous growth opportunities for players operating in the vascular grafts.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type - Tier 1 – 60% and Tier 2 – 40%
- By Designation – C level – 62%, Director level – 21%, Others – 17%
- By Region – North America – 50%, Europe – 20%, Asia– 30%
Research Coverage:
The report analyses the vascular grafts market by indication, raw material, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. This report also includes market research data, current market size, and forecast of the future trends that will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the vascular grafts market
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the vascular grafts market.
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vascular grafts market.
- Market Development: Comprehensive information about emerging markets. This report analyses the market for various vascular grafts products across geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular grafts market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VASCULAR GRAFTS: MARKET OVERVIEW
4.2 VASCULAR GRAFTS MARKET, BY END USER
4.3 EUROPE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL
4.4 GEOGRAPHIC SNAPSHOT OF THE VASCULAR GRAFTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the aging population and the associated increase in the prevalence of aneurysm
5.2.1.2 Increasing prevalence of smoking
5.2.1.3 Increasing incidence of ESRD
5.2.1.4 Growing adoption of minimally invasive surgeries
5.2.2 RESTRAINT
5.2.2.1 Product failures and recalls
5.2.3 OPPORTUNITY
5.2.3.1 Emerging markets
5.2.4 TREND
5.2.4.1 Development of biosynthetic vascular grafts
6 VASCULAR GRAFTS MARKET, BY RAW MATERIAL
6.1 INTRODUCTION
6.2 POLYESTER GRAFTS
6.3 EPTFE GRAFTS
6.4 POLYURETHANE GRAFTS
6.5 BIOSYNTHETIC GRAFTS
7 GLOBAL VASCULAR GRAFTS MARKET, BY INDICATION
7.1 INTRODUCTION
7.2 ENDOVASCULAR ANEURYSM REPAIR
7.2.1 ABDOMINAL AORTIC ANEURYSMS REPAIR
7.2.2 THORACIC AORTIC ANEURYSM REPAIR
7.3 PERIPHERAL VASCULAR REPAIR
7.4 HEMODIALYSIS ACCESS
8 VASCULAR GRAFTS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 AMBULATORY SURGICAL CENTERS
9 VASCULAR GRAFTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 ROE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 AUSTRALIA
9.4.4 INDIA
9.4.5 ROAPAC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, 2016
10.3 COMPETITIVE SCENARIO
10.3.1 PRODUCT LAUNHCES
10.3.2 ACQUISITIONS
10.3.3 EXPANSIONS
10.3.4 AGREEMENTS
10.3.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 MEDTRONIC
11.2 TERUMO
11.3 C. R. BARD
11.4 B. BRAUN MELSUNGEN AG
11.5 CARDINAL HEALTH
11.6 ENDOLOGIX
11.7 LEMAITRE VASCULAR
11.8 COOK MEDICAL
11.9 MAQUET
11.10 GORE MEDICAL
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VASCULAR GRAFTS: MARKET OVERVIEW
4.2 VASCULAR GRAFTS MARKET, BY END USER
4.3 EUROPE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL
4.4 GEOGRAPHIC SNAPSHOT OF THE VASCULAR GRAFTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the aging population and the associated increase in the prevalence of aneurysm
5.2.1.2 Increasing prevalence of smoking
5.2.1.3 Increasing incidence of ESRD
5.2.1.4 Growing adoption of minimally invasive surgeries
5.2.2 RESTRAINT
5.2.2.1 Product failures and recalls
5.2.3 OPPORTUNITY
5.2.3.1 Emerging markets
5.2.4 TREND
5.2.4.1 Development of biosynthetic vascular grafts
6 VASCULAR GRAFTS MARKET, BY RAW MATERIAL
6.1 INTRODUCTION
6.2 POLYESTER GRAFTS
6.3 EPTFE GRAFTS
6.4 POLYURETHANE GRAFTS
6.5 BIOSYNTHETIC GRAFTS
7 GLOBAL VASCULAR GRAFTS MARKET, BY INDICATION
7.1 INTRODUCTION
7.2 ENDOVASCULAR ANEURYSM REPAIR
7.2.1 ABDOMINAL AORTIC ANEURYSMS REPAIR
7.2.2 THORACIC AORTIC ANEURYSM REPAIR
7.3 PERIPHERAL VASCULAR REPAIR
7.4 HEMODIALYSIS ACCESS
8 VASCULAR GRAFTS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 AMBULATORY SURGICAL CENTERS
9 VASCULAR GRAFTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 ROE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 AUSTRALIA
9.4.4 INDIA
9.4.5 ROAPAC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, 2016
10.3 COMPETITIVE SCENARIO
10.3.1 PRODUCT LAUNHCES
10.3.2 ACQUISITIONS
10.3.3 EXPANSIONS
10.3.4 AGREEMENTS
10.3.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 MEDTRONIC
11.2 TERUMO
11.3 C. R. BARD
11.4 B. BRAUN MELSUNGEN AG
11.5 CARDINAL HEALTH
11.6 ENDOLOGIX
11.7 LEMAITRE VASCULAR
11.8 COOK MEDICAL
11.9 MAQUET
11.10 GORE MEDICAL
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 2 EXAMPLES OF POLYESTER GRAFTS OFFERED BY MARKET LEADERS
Table 3 POLYESTER VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 4 SYNTHETIC POLYMERS: IN VIVO VASCULAR REGENERATION
Table 5 EXAMPLES OF EPTFE GRAFTS OFFERED BY MARKET LEADERS
Table 6 EPTFE VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 7 EXAMPLES OF POLYURETHANE GRAFTS OFFERED BY MARKET LEADERS
Table 8 POLYURETHANE VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 9 BIOSYNTHETIC VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 10 VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 11 EVAR GRAFTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 12 EVAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 13 ABDOMINAL AORTIC ANEURYSM REPAIR MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 14 THORACIC AORTIC ANEURYSM REPAIR MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 15 PERIPHERAL VASCULAR REPAIR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 16 HEMODIALYSIS ACCESS GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 17 VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 18 VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION, 2015–2022 (USD MILLION)
Table 19 VASCULAR GRAFTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
Table 20 GLOBAL VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 21 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 23 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 24 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 25 INDICATIVE LIST OF RECENT EVENTS IN THE US
Table 26 US: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 27 US : VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 28 US: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 29 CANADA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 30 CANADA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 31 CANADA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 32 GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL), 2005 VS. 2015 VS. 2025
Table 33 EUROPE: VASCULAR GRAFTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 34 EUROPE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 35 EUROPE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 36 EUROPE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 37 GERMANY: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 38 GERMANY: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 39 GERMANY: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 40 UK: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 41 UK: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 42 UK: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 43 FRANCE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 44 FRANCE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 45 FRANCE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 46 ITALY: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 47 ITALY: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 48 ITALY: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 49 ROE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 50 ROE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 51 ROE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 52 PROPORTION OF OLDER PERSONS IN LABOUR FORCE AGED 65+, FOR SELECTED COUNTRIES (2016)
Table 53 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 54 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 55 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 56 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 57 CHINA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 58 CHINA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 59 CHINA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 60 JAPAN: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 61 JAPAN: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 62 JAPAN: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 63 AUSTRALIA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 64 AUSTRALIA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 65 AUSTRALIA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 66 INDIA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 67 INDIA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 68 INDIA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 69 ROAPAC: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 70 ROAPAC: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 71 ROAPAC: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 72 OBESITY PREVALENCE IN LATIN AMERICA, BY COUNTRY, 2014
Table 73 ROW: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 74 ROW: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 75 ROW: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 1 VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 2 EXAMPLES OF POLYESTER GRAFTS OFFERED BY MARKET LEADERS
Table 3 POLYESTER VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 4 SYNTHETIC POLYMERS: IN VIVO VASCULAR REGENERATION
Table 5 EXAMPLES OF EPTFE GRAFTS OFFERED BY MARKET LEADERS
Table 6 EPTFE VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 7 EXAMPLES OF POLYURETHANE GRAFTS OFFERED BY MARKET LEADERS
Table 8 POLYURETHANE VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 9 BIOSYNTHETIC VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 10 VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 11 EVAR GRAFTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 12 EVAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 13 ABDOMINAL AORTIC ANEURYSM REPAIR MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 14 THORACIC AORTIC ANEURYSM REPAIR MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 15 PERIPHERAL VASCULAR REPAIR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 16 HEMODIALYSIS ACCESS GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 17 VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 18 VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION, 2015–2022 (USD MILLION)
Table 19 VASCULAR GRAFTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
Table 20 GLOBAL VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 21 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 23 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 24 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 25 INDICATIVE LIST OF RECENT EVENTS IN THE US
Table 26 US: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 27 US : VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 28 US: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 29 CANADA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 30 CANADA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 31 CANADA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 32 GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL), 2005 VS. 2015 VS. 2025
Table 33 EUROPE: VASCULAR GRAFTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 34 EUROPE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 35 EUROPE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 36 EUROPE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 37 GERMANY: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 38 GERMANY: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 39 GERMANY: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 40 UK: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 41 UK: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 42 UK: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 43 FRANCE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 44 FRANCE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 45 FRANCE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 46 ITALY: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 47 ITALY: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 48 ITALY: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 49 ROE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 50 ROE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 51 ROE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 52 PROPORTION OF OLDER PERSONS IN LABOUR FORCE AGED 65+, FOR SELECTED COUNTRIES (2016)
Table 53 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 54 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 55 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 56 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 57 CHINA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 58 CHINA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 59 CHINA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 60 JAPAN: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 61 JAPAN: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 62 JAPAN: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 63 AUSTRALIA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 64 AUSTRALIA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 65 AUSTRALIA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 66 INDIA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 67 INDIA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 68 INDIA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 69 ROAPAC: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 70 ROAPAC: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 71 ROAPAC: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 72 OBESITY PREVALENCE IN LATIN AMERICA, BY COUNTRY, 2014
Table 73 ROW: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION)
Table 74 ROW: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
Table 75 ROW: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION)
LIST OF FIGURES
Figure 1 GLOBAL VASCULAR GRAFTS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 DATA TRIANGULATION METHODOLOGY
Figure 5 VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2017 VS. 2022 (USD BILLION)
Figure 6 VASCULAR GRAFTS MARKET, BY INDICATION, 2017 VS. 2022 (USD BILLION)
Figure 7 VASCULAR GRAFTS MARKET, BY END USER 2017 VS. 2022 (USD BILLION)
Figure 8 VASCULAR GRAFTS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION)
Figure 9 INCREASING GERIATRIC POPULATION AND HIGH PREVALENCE OF ANEURYSMS TO DRIVE THE MARKET
Figure 10 HOSPITALS TO DOMINATE THE VASCULAR GRAFTS MARKET DURING THE FORECAST PERIOD
Figure 11 POLYESTER GRAFTS TO DOMINATE THE EUROPEAN VASCULAR GRAFTS MARKET IN 2017
Figure 12 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 13 VASCULAR GRAFTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
Figure 14 GLOBAL GERIATRIC POPULATION (60 YEARS AND ABOVE), 2015 VS. 2030 (MILLION)
Figure 15 POLYESTER GRAFTS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 16 EVAR SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 17 HOSPITALS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 18 VASCULAR GRAFTS MARKET IN ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 19 NORTH AMERICA MARKET SNAPSHOT
Figure 20 EUROPE SNAPSHOT
Figure 21 ASIA PACIFIC MARKET SNAPSHOT
Figure 22 ROW VASCULAR GRAFTS MARKET SNAPSHOT
Figure 23 KEY DEVELOPMENTS ADOPTED BY THE TOP PLAYERS IN VASCULAR GRAFTS MARKET BETWEEN 2014 AND 2017
Figure 24 SHARES OF COMPANIES IN THE VASCULAR GRAFTS MARKET, 2016
Figure 25 MEDTRONIC: COMPANY SNAPSHOT
Figure 26 TERUMO: COMPANY SNAPSHOT
Figure 27 C. R. BARD: COMPANY SNAPSHOT
Figure 28 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
Figure 29 CARDINAL HEALTH: COMPANY SNAPSHOT
Figure 30 ENDOLOGIX: COMPANY SNAPSHOT
Figure 31 LEMAITRE VASCULAR: COMPANY SNAPSHOT
Figure 1 GLOBAL VASCULAR GRAFTS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 DATA TRIANGULATION METHODOLOGY
Figure 5 VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2017 VS. 2022 (USD BILLION)
Figure 6 VASCULAR GRAFTS MARKET, BY INDICATION, 2017 VS. 2022 (USD BILLION)
Figure 7 VASCULAR GRAFTS MARKET, BY END USER 2017 VS. 2022 (USD BILLION)
Figure 8 VASCULAR GRAFTS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION)
Figure 9 INCREASING GERIATRIC POPULATION AND HIGH PREVALENCE OF ANEURYSMS TO DRIVE THE MARKET
Figure 10 HOSPITALS TO DOMINATE THE VASCULAR GRAFTS MARKET DURING THE FORECAST PERIOD
Figure 11 POLYESTER GRAFTS TO DOMINATE THE EUROPEAN VASCULAR GRAFTS MARKET IN 2017
Figure 12 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 13 VASCULAR GRAFTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
Figure 14 GLOBAL GERIATRIC POPULATION (60 YEARS AND ABOVE), 2015 VS. 2030 (MILLION)
Figure 15 POLYESTER GRAFTS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 16 EVAR SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 17 HOSPITALS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 18 VASCULAR GRAFTS MARKET IN ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 19 NORTH AMERICA MARKET SNAPSHOT
Figure 20 EUROPE SNAPSHOT
Figure 21 ASIA PACIFIC MARKET SNAPSHOT
Figure 22 ROW VASCULAR GRAFTS MARKET SNAPSHOT
Figure 23 KEY DEVELOPMENTS ADOPTED BY THE TOP PLAYERS IN VASCULAR GRAFTS MARKET BETWEEN 2014 AND 2017
Figure 24 SHARES OF COMPANIES IN THE VASCULAR GRAFTS MARKET, 2016
Figure 25 MEDTRONIC: COMPANY SNAPSHOT
Figure 26 TERUMO: COMPANY SNAPSHOT
Figure 27 C. R. BARD: COMPANY SNAPSHOT
Figure 28 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
Figure 29 CARDINAL HEALTH: COMPANY SNAPSHOT
Figure 30 ENDOLOGIX: COMPANY SNAPSHOT
Figure 31 LEMAITRE VASCULAR: COMPANY SNAPSHOT
